CRYO-CELL INTL INC (CCEL) Stock Fundamental Analysis
USA - NYSEARCA:CCEL - US2288951088 - Common Stock
4.401 USD
-0.11 (-2.5%)
4.55 USD
+0.15 (+3.39%)
Taking everything into account, CCEL scores 3 out of 10 in our fundamental rating. CCEL was compared to 101 industry peers in the Health Care Providers & Services industry. While CCEL is still in line with the averages on profitability rating, there are concerns on its financial health. CCEL has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CCEL has reported negative net income.
CCEL had a positive operating cash flow in the past year.
CCEL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CCEL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CCEL (-0.27%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 7.06%, CCEL is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CCEL is in line with the industry average of 9.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.27% | ||
| ROE | N/A | ||
| ROIC | 7.06% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
In the last couple of years the Profit Margin of CCEL has declined.
Looking at the Operating Margin, with a value of 11.93%, CCEL belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
CCEL's Operating Margin has declined in the last couple of years.
The Gross Margin of CCEL (76.23%) is better than 90.10% of its industry peers.
CCEL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.93% | ||
| PM (TTM) | N/A | ||
| GM | 76.23% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCEL is destroying value.
Compared to 1 year ago, CCEL has less shares outstanding
Compared to 5 years ago, CCEL has more shares outstanding
Compared to 1 year ago, CCEL has an improved debt to assets ratio.
2.2 Solvency
CCEL has an Altman-Z score of 0.03. This is a bad value and indicates that CCEL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.03, CCEL is doing worse than 78.22% of the companies in the same industry.
The Debt to FCF ratio of CCEL is 1.42, which is an excellent value as it means it would take CCEL, only 1.42 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.42, CCEL belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.42 | ||
| Altman-Z | 0.03 |
ROIC/WACC0.6
WACC11.71%
2.3 Liquidity
CCEL has a Current Ratio of 0.60. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEL's Current ratio of 0.60 is on the low side compared to the rest of the industry. CCEL is outperformed by 89.11% of its industry peers.
A Quick Ratio of 0.57 indicates that CCEL may have some problems paying its short term obligations.
The Quick ratio of CCEL (0.57) is worse than 86.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.20% over the past year.
The earnings per share for CCEL have been decreasing by -29.04% on average. This is quite bad
CCEL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.10%.
Measured over the past years, CCEL shows a small growth in Revenue. The Revenue has been growing by 0.11% on average per year.
EPS 1Y (TTM)98.2%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-50%
Revenue 1Y (TTM)1.1%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-0.89%
3.2 Future
Based on estimates for the next years, CCEL will show a very negative growth in Earnings Per Share. The EPS will decrease by -96.72% on average per year.
CCEL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.09% yearly.
EPS Next Y-100%
EPS Next 2Y-96.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.13%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CCEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCEL is valued cheaper than 82.18% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCEL is valued cheaper than 96.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.97 | ||
| EV/EBITDA | 7.5 |
4.3 Compensation for Growth
CCEL's earnings are expected to decrease with -96.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-96.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCEL has a Yearly Dividend Yield of 19.53%, which is a nice return.
CCEL's Dividend Yield is rather good when compared to the industry average which is at 2.42. CCEL pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 19.53% |
5.2 History
CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-3067.58%
EPS Next 2Y-96.72%
EPS Next 3YN/A
4.401
-0.11 (-2.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.28%
Inst Owner Change0%
Ins Owners40.67%
Ins Owner Change1.47%
Market Cap35.47M
Revenue(TTM)31.99M
Net Income(TTM)-171200
Analysts82.86
Price Target8.67 (97%)
Short Float %0.21%
Short Ratio0.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 19.53% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-3067.58%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-0.9%
Revenue beat(4)0
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-1.76%
Revenue beat(12)3
Avg Revenue beat(12)-0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.11 | ||
| P/FCF | 5.97 | ||
| P/OCF | 5.67 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.5 |
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.74
FCFY16.74%
OCF(TTM)0.78
OCFY17.63%
SpS3.97
BVpS-1.93
TBVpS-2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.27% | ||
| ROE | N/A | ||
| ROCE | 8.94% | ||
| ROIC | 7.06% | ||
| ROICexc | 7.88% | ||
| ROICexgc | 8.51% | ||
| OM | 11.93% | ||
| PM (TTM) | N/A | ||
| GM | 76.23% | ||
| FCFM | 18.56% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.42 | ||
| Debt/EBITDA | 1.71 | ||
| Cap/Depr | 32.05% | ||
| Cap/Sales | 1% | ||
| Interest Coverage | 1.89 | ||
| Cash Conversion | 130.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | 0.03 |
F-Score7
WACC11.71%
ROIC/WACC0.6
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.2%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-50%
EPS Next Y-100%
EPS Next 2Y-96.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.1%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-0.89%
Revenue Next Year-0.13%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.29%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year22.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y238.22%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-28.52%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
What is the fundamental rating for CCEL stock?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
Can you provide the valuation status for CRYO-CELL INTL INC?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
What is the financial health of CRYO-CELL INTL INC (CCEL) stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.